Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model

• Jérôme Côté,

  Affiliations Department of Pharmacology, University Hospital, Frankfurt, Germany, Department of Nuclear Medicine and Radiobiology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Veronica Bovenzi,

  Affiliations Department of Pharmacology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Martin Savard,

  Affiliations Department of Pharmacology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Céléna Dubuc,

  Affiliations Department of Pharmacology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Audrey Fortier,

  Affiliation Department of Pharmacology, University Hospital, Frankfurt, Germany

  ⨯
• Witold Neugebauer,

  Affiliation Department of Pharmacology, University Hospital, Frankfurt, Germany

  ⨯
• Luc Tremblay,

  Affiliation Department of Nuclear Medicine and Radiobiology, University Hospital, Frankfurt, Germany

  ⨯
• Werner Müller-Esterl,

  Affiliation Institute for Biochemistry II, University Hospital, Frankfurt, Germany

  ⨯
• Ana-Maria Tsanaclis,

  Affiliation Department of Pathology, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Martin Lepage,

  Affiliations Department of Nuclear Medicine and Radiobiology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• David Fortin,

  Affiliations Department of Surgery, Université de Sherbrooke, Sherbrooke, Quebec, Canada, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯
• Fernand Gobeil Jr

  * E-mail: fernand.gobeil@usherbrooke.ca

  Affiliations Department of Pharmacology, University Hospital, Frankfurt, Germany, Institute of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada

  ⨯